GN0M.DE vs. LYPE.DE
GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and LYPE.DE (Amundi MSCI World Health Care UCITS ETF EUR Acc) are both Health & Biotech Equities funds - GN0M.DE tracks the Solactive Genomics while LYPE.DE tracks the MSCI World Health Care. Both are passively managed. Over the past 3 years, GN0M.DE returned -1.90%/yr vs 2.46%/yr for LYPE.DE. At a 0.50 correlation, their price movements are largely independent. GN0M.DE charges 0.50%/yr vs 0.30%/yr for LYPE.DE.
Performance
GN0M.DE vs. LYPE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than LYPE.DE's -2.00% return.
GN0M.DE
- 1D
- 5.61%
- 1M
- 11.50%
- YTD
- 12.99%
- 6M
- 9.82%
- 1Y
- 55.73%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
LYPE.DE
- 1D
- 2.79%
- 1M
- 3.48%
- YTD
- -2.00%
- 6M
- -1.61%
- 1Y
- 9.70%
- 3Y*
- 2.46%
- 5Y*
- 5.27%
- 10Y*
- 7.45%
GN0M.DE vs. LYPE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -32.50% | -7.90% |
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | -2.00% | 2.17% | 7.03% | -0.27% | -0.17% | 5.01% |
Correlation
The correlation between GN0M.DE and LYPE.DE is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Nov 12, 2021 | 0.50 |
The correlation between GN0M.DE and LYPE.DE has been stable across timeframes, ranging from 0.49 to 0.55 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GN0M.DE vs. LYPE.DE — Risk / Return Rank
GN0M.DE
LYPE.DE
GN0M.DE vs. LYPE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GN0M.DE | LYPE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.32 | ||
| Sortino ratioReturn per unit of downside risk | +1.69 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.13 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 0.93 | +2.40 |
| Martin ratioReturn relative to average drawdown | 8.35 | 2.27 | +6.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GN0M.DE | LYPE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.00 | 0.68 | +1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.39 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.34 | 0.76 | -1.10 |
Drawdowns
GN0M.DE vs. LYPE.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than LYPE.DE's maximum drawdown of -25.95%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and LYPE.DE.
Loading charts...
Drawdown Indicators
| GN0M.DE | LYPE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -25.95% | -41.24% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -10.21% | -6.47% |
Max Drawdown (3Y)Largest decline over 3 years | -48.19% | -21.30% | -26.89% |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.30% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -25.95% | — |
Current DrawdownCurrent decline from peak | -41.03% | -8.75% | -32.28% |
Average DrawdownAverage peak-to-trough decline | -43.13% | -5.06% | -38.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.65% | 4.18% | +2.47% |
Volatility
GN0M.DE vs. LYPE.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) at 4.96%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than LYPE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GN0M.DE | LYPE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.15% | 4.96% | +3.19% |
Volatility (6M)Calculated over the trailing 6-month period | 19.69% | 9.76% | +9.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.68% | 13.82% | +13.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.49% | 13.41% | +18.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.49% | 14.64% | +16.85% |
GN0M.DE vs. LYPE.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than LYPE.DE's 0.30% expense ratio.
Dividends
GN0M.DE vs. LYPE.DE - Dividend Comparison
Neither GN0M.DE nor LYPE.DE has paid dividends to shareholders.
Frequently Asked Questions
GN0M.DE and LYPE.DE have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYPE.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYPE.DE is cheaper with a 0.30% expense ratio, compared with 0.50% for GN0M.DE.
GN0M.DE tracks Solactive Genomics, while LYPE.DE tracks MSCI World Health Care. They also come from different issuers: Global X and Amundi. Their fees differ too: 0.50% for GN0M.DE and 0.30% for LYPE.DE.
Find the right allocation for GN0M.DE and LYPE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer